Changzhou Institute of Materia Medica Co., Ltd. announced that it has received funding on September 29, 2024. The transaction included participation from new investors Jiangxi Financial Holding Group Co.,Ltd.,Changzhou Hi-tech Group Co.,Ltd,CSC Financial Co., Ltd.,Zhejiang Qingsong Investment Management Co., Ltd. and Qitai Capital.